Jeff Yass’s PharMerica Corporation PMC Stock Holding History

Jeff Yass’s Portfolio PMC Stock Details PMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-11,000	Closed	-$289K	–	10169
2017 Q2	$289K	Sell	11,000 -12,200	-53%	-$300K	﹤0.01%	7653
2017 Q1	$543K	Buy	+23,200	New	+$573K	﹤0.01%	6330
2015 Q3	–	Sell	-7,500	Closed	-$250K	–	10631
2015 Q2	$250K	Buy	+7,500	New	+$230K	﹤0.01%	8886
2015 Q1	–	Sell	-12,800	Closed	-$265K	–	10308
2014 Q4	$265K	Buy	+12,800	New	+$304K	﹤0.01%	8340
2014 Q2	–	Sell	-7,200	Closed	-$201K	–	10328
2014 Q1	$201K	Buy	+7,200	New	+$177K	﹤0.01%	8232

Other funds holding PMC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WIC

Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Jeff Yass's PMC Position: Q1 2017 in Review

Jeff Yass sold out of PharMerica Corporation (PMC) in Q1 2017, closing a stake of 57,204 shares — an estimated $1.41M sold.

Jeff Yass first reported a position in PMC in Q2 2013 and held it in 4 quarters. The position peaked at $1.89M in Q2 2014. 152 funds tracked by Wall St. Rank hold PMC as of Q1 2017.

Jeff Yass reported no remaining PharMerica Corporation position as of Q1 2017 after selling out during the quarter.
Jeff Yass sold 57,204 PharMerica Corporation shares in Q1 2017, an estimated $1.41M.
Jeff Yass first reported a position in PharMerica Corporation in Q2 2013 and held it in 4 quarters.
Jeff Yass's PharMerica Corporation position peaked at $1.89M in Q2 2014.
152 funds tracked by Wall St. Rank held PharMerica Corporation as of Q1 2017.

Based on Susquehanna International Group's 13F filing for Q1 2017, filed 15 May 2017.